bioRxivGeneticsPreprint
Large-scale Perturbation of Systems Biology-Derived Genes Reveals Modifiers of HD-associated Transcriptomic Networks and Pathology
Peter LangfelderiD, Nan WangiD, Lalini RamanathaniD, Young Mi OhiD, Seongwon Lee, Fuying GaoiD, Xiaofeng GuiD, Matthew Stricos, Mary Plascencia, Raymond VacaiD, Jeffrey RichmaniD, Thomas VogtiD, Steve HorvathiD, Andrew S.J. YooiD, Jeffrey S. Aaronson, Jim Rosinski, X. William YangiD
- Citations
- 0
Abstract
In Huntingtons disease (HD), disease-driver genes are broadly expressed, but pathogenic players specific to vulnerable neurons remain poorly defined. Leveraging a previously defined mutant huntingtin (mHtt) CAG-length-associated gene network, we perturbed 115 module hub genes with heterozygous knockout (KO-het) to assess their striatal transcriptomic modifier effects in wildtype and Q140 HD mice. We generated 3,592 striatal RNA-seq datasets, mapped 6,517 perturbagen-responder gene pairs, and uncovered regulators of medium spiny neuron (MSN) identity gene expression and DNA- methylase/demethylase-sensitive genes. We developed a bioinformatic pipeline to rank the perturbations with significant impacts on striatal transcriptome and HD-associated gene networks in wildtype or Q140 mice. KO-het for FoxP1 and Scn4b (two MSN-selective genes) exacerbated, whereas Pdp1 KO-het ameliorated, Q140 striatal pathology. Importantly, knockdown of functionally opposing ion channels, SCN4B and KCNH4, dichotomously affected aggregation and neurodegeneration in reprogrammed HD patient MSNs. Together, our study rigorously evaluated systems biology-derived candidates to identify modifiers of HD-associated molecular networks and pathology, providing an in vivo perturbation- transcriptome resource and highlighting genes involved in MSN excitability, transcription, calcium signaling, and mitochondrial metabolism in HD pathogenesis.
- organism: mouse
- assay: bulk RNA-seq
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-nucleus RNA-seq reveals dysregulation of striatal cell identity due to Huntington’s disease mutations
Sonia Malaiya, Marcia Cortes-Gutierrez, … Seth A. Ament·Journal of NeurosciencePeer-reviewed·May 19, 2021
- Transcriptomic Characterization Reveals Disrupted Medium Spiny Neuron Trajectories in Huntington's Disease and Possible Therapeutic Avenues
Carlos Galicia Aguirre, Kizito‐Tshitoko Tshilenge, … Lisa Ellerby·bioRxiv·Apr 30, 2023
- Scn4b Modulates Huntington's Disease Phenotype Severity in vivo
Suphinya Sathitloetsakun, Vanessa Farrell, … Myriam Heiman·bioRxiv·Mar 10, 2026
- Huntingtin loss-of-function contributes to transcriptional deregulation in Huntington's disease
Emilia Kozłowska, Agata Ciołak, … Agnieszka Fiszer·Cell & BiosciencePeer-reviewed·Jul 9, 2025
- A meta-analysis of transcriptomic profiles from Huntington's disease patients points to a pathophysiological role of CDC42, NFY, DLX1 and PRMT3
Manuel Seefelder, Stefan Kochanek·PLoS ONEPeer-reviewed·Jun 10, 2021
- Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
Nan Wang, Shasha Zhang, … X. William Yang·bioRxiv·Jul 9, 2024